Insight into Prevention of Neisseria Gonorrhoeae: A Short Review

An Observational Study to Assess the Effectiveness of 4CMenB against Meningococcal Disease and Carriage and Gonorrhea in Adolescents in the Northern Territory, Australia—Study Protocol

(2022) Helen S. Marshall et al.   Vaccines

Prevention of Neisseria gonorrhoeae with meningococcal B vaccine: a matched cohort study in Southern California

(2022) Katia J Bruxvoort et al.   CLINICAL INFECTIOUS DISEASES

Effectiveness of a serogroup B outer membrane vesicle meningococcal vaccine against gonorrhoea: a retrospective observational study

(2022) Winston E Abara et al.   LANCET INFECTIOUS DISEASES

Effectiveness and impact of the 4CMenB vaccine against invasive serogroup B meningococcal disease and gonorrhoea in an infant, child, and adolescent programme: an observational cohort and case-control study

(2022) Bing Wang et al.   LANCET INFECTIOUS DISEASES

Recent Progress Towards a Gonococcal Vaccine

(2022) Stavros A. Maurakis et al.   Frontiers in Cellular and Infection Microbiology

VA-MENGOC-BC Vaccination Induces Serum and Mucosal Anti Neisseria gonorrhoeae Immune Responses and Reduces the Incidence of Gonorrhea

(2021) Laura M. Reyes Díaz et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

The potential utility of liposomes for Neisseria vaccines

(2021) Myron Christodoulides et al.   Expert Review of Vaccines

Sexually Transmitted Infections Treatment Guidelines, 2021

(2021) Kimberly A. Workowski et al.   MMWR Recommendations and Reports

WHO global antimicrobial resistance surveillance for Neisseria gonorrhoeae 2017–18: a retrospective observational study

(2021) Magnus Unemo et al.   Lancet Microbe

Looking beyond meningococcal B with the 4CMenB vaccine: the Neisseria effect

(2021) Yara Ruiz García et al.   npj Vaccines

Synergic complement‐mediated bactericidal activity of monoclonal antibodies with distinct specificity

(2020) Eriberto Noel Natali et al.   FASEB JOURNAL

Characteristics of Neisseria Species Colonized in the Human’s Nasopharynx

(2020) Ali Mehrabi Tavana et al.   Jundishapur Journal of Microbiology

Exploitation of Neisseria meningitidis Group B OMV Vaccines Against N. gonorrhoeae to Inform the Development and Deployment of Effective Gonorrhea Vaccines

(2019) Helen Petousis-Harris et al.   Frontiers in Immunology

Genetic Similarity of Gonococcal Homologs to Meningococcal Outer Membrane Proteins of Serogroup B Vaccine

(2019) Henju Marjuki et al.   mBio

Meningococcal Group B Vaccine For The Prevention Of Invasive Meningococcal Disease Caused By Neisseria meningitidis Serogroup B

(2019) Irene Rivero-Calle et al.   Infection and Drug Resistance

Human protective response induced by meningococcus B vaccine is mediated by the synergy of multiple bactericidal epitopes

(2018) M. Giuliani et al.   Scientific Reports

The serogroup B meningococcal vaccine Bexsero elicits antibodies to Neisseria gonorrhoeae

(2018) Evgeny A Semchenko et al.   CLINICAL INFECTIOUS DISEASES

Meningococcal B vaccine (4CMenB): the journey from research to real world experience

(2018) Rino Rappuoli et al.   Expert Review of Vaccines

Macrophage–Neisseria gonorrhoeae Interactions: A Better Understanding of Pathogen Mechanisms of Immunomodulation

(2018) Alejandro Escobar et al.   Frontiers in Immunology

Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study

(2017) Helen Petousis-Harris et al.   LANCET

Experimental vaccine induces Th1-driven immune responses and resistance to Neisseria gonorrhoeae infection in a murine model

(2017) Y Liu et al.   Mucosal Immunology

Can we control all-cause meningococcal disease in Europe?

(2016) M. Sadarangani et al.   CLINICAL MICROBIOLOGY AND INFECTION

Role of Factor H Binding Protein in Neisseria meningitidis Virulence and Its Potential as a Vaccine Candidate To Broadly Protect against Meningococcal Disease

(2013) L. K. McNeil et al.   MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS

Cooperative serum bactericidal activity between human antibodies to meningococcal factor H binding protein and Neisserial heparin binding antigen

(2011) David M. Vu et al.   VACCINE